Innovation has remained high on the administration’s agenda, as is evident from the allocations to tackle climate changes as well as find treatments for devastating health conditions.
President Obama released his budget for fiscal year 2017 today. Innovation in diverse fields has remained high on the administration’s agenda, as is evident from the allocations to tackle climate changes as well as find treatments for devastating health conditions.
The following is a summary of some of the investments in the proposal:
1. Basic Research
With more than $900 million over the 2016 allocation, the Budget provides $14.6 billion in the year 2017 for the National Science Foundation, the Department of Energy’s Office of Science, and the National Institute of Standards and Technology, which invest in basic research.
2. Cancer Moonshot
After the President handed the baton for leading federal efforts on cancer research to Vice President Biden during his State of the Union speech, Biden staffers have had a busy schedule meeting with top research scientists and organizations around the country to forward their efforts. Now, the President has supported the effort with a $1 billion initiative to provide the funding necessary for researchers to accelerate the development of new cancer detection and treatments.
The bifurcation includes $195 million in new cancer activities at the National Institutes of Health (NIH) in Fiscal Year 2016, $755 million in mandatory funds in the 2017 Budget for new cancer-related research activities at both NIH and the FDA, and support from other agencies such as the Departments of Defense and Veterans Affairs.
3. Supporting Biomedical Research
Nearly 10,000 new and competing NIH grants will be provided with $33.1 billion in funding support to promote programs like the BRAIN Initiative and the Precision Medicine Initiative.
4. Research and Experimentation Tax Credit
The government wants the private industrial sector to continue to expand investment innovative technologies/programs. The incentive? A Research and Experimentation Tax Credit, which the government had offered to small businesses last year.
5. Expanding the Healthcare Workforce
Allocations to expand the provider workforce include expanding and extending funding for the National Health Services Corps through Fiscal Year 2020.
6. Expanding Access to Quality, Affordable Healthcare
In addition to the Affordable Care Act, which the Budget already supports, the following initiatives have found support in the 2017 Budget:
a. Mental Health Care. The Budget includes $500 million in new mandatory funding to engage individuals with serious mental illness in care, improve access to care, and ensure that behavioral healthcare systems work.
b. Prescription Drug and Heroin Overdose. With a 2-pronged approach, the Budget includes a mandatory 2-year funding to expand access to treatment for prescription drug abuse and heroin use, and funding to continue and increase current efforts to expand State-level prescription drug overdose prevention strategies, increase the availability of medication-assisted treatment programs, improve access to the overdose-reversal drug naloxone, and support targeted enforcement activities.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More